GTHP OTC
Guided Therapeutics, Inc.
1W: -11.3%
1M: -12.0%
3M: -21.4%
YTD: -59.3%
1Y: -18.5%
3Y: +46.7%
5Y: -60.4%
$0.22
-0.03 (-11.25%)
Weekly Expected Move ±26.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$571K
+28450.0% ▲
5Y CAGR: +31.9%
Operating Income
-$2M
-12.5% ▼
Net Income
-$3M
-38.4% ▼
EPS (Diluted)
$-0.04
+11.5% ▲
EBITDA
-$2M
-22.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $81K | $13K | $98K | $7K | $0 |
| YoY Growth | -20.6% | -84.0% | +653.8% | -92.9% | -100.0% |
| Cost of Revenue | $61K | $81K | $62K | $5K | $0 |
| Gross Profit | $20K | -$68K | $36K | $2K | $571K |
| Gross Margin | 24.7% | -523.1% | 36.7% | 28.6% | — |
| R&D Expenses | $69K | $77K | $228K | $526K | $469K |
| SG&A Expenses | $2M | $3M | $3M | $2M | $2M |
| Operating Expenses | $2M | $3M | $3M | $2M | $3M |
| Operating Income | -$2M | -$3M | -$3M | -$2M | -$2M |
| Operating Margin | -2916.0% | -25638.5% | -3527.6% | -30114.3% | — |
| Interest Expense | $1M | $582K | $278K | $381K | -$617K |
| Income Before Tax | -$2M | -$4M | -$3M | -$2M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $150K |
| Net Income | -$2M | -$4M | -$3M | -$2M | -$3M |
| Net Margin | -2555.6% | -33392.3% | -3560.2% | -34528.6% | — |
| EPS (Diluted) | $-0.18 | $-0.15 | $-0.07 | $-0.05 | $-0.04 |
| EBITDA | -$919K | -$4M | -$3M | -$2M | -$2M |
| Shares Outstanding | 13M | 33M | 51M | 57M | 78M |